POPULATION PHARMACOKINETICS RAYMOND MILLER, D.Sc. Pfizer Global Research and Development RAYMOND MILLER, D.Sc. Pfizer Global Research and Development.
Expect the unexpected An example of how unanticipated fragmentation behaviour could preclude correct assignment of sites of metabolism Stephen W. Holman.
Oates pj cv 10 17 13
Adaptive Design
OatesPJ cv 7 30 2015
9781441973573-c1.pdf
1 Black Box Warnings (& Other Concerns) A to Z Emory S. Martin III, PharmD BCPS Vice President, Pharmacy Services Scott & White Healthcare.
1 Metabolic Activation and Idiosycratic Drug Toxicity: By Avoiding Structural Alerts, Do We Mitigate Risks? Amit S. Kalgutkar, Ph.D. Pfizer Global Research.
P07 (04) - Finite Element Analysis of Capping Mechanisms During Pharmaceutical Powder Compaction
Stephen W. Holman 8 th September 2008 [email protected]
5th International Workshop on Clinical Pharmacology of HIV Therapy – Rome 2004 Posters - L. Akagi.
